Cargando…

Early Use of Rituximab in Calcineurin Inhibitor–Refractory and Steroid-Resistant Nephrotic Syndrome

Detalles Bibliográficos
Autores principales:	Sinha, Rajiv, Banerjee, Sushmita, Mukherjee, Anwesha, Pradhan, Subal, Akhtar, Shakil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710833/ https://www.ncbi.nlm.nih.gov/pubmed/33305130 http://dx.doi.org/10.1016/j.ekir.2020.09.021

Ejemplares similares

Intravenous Immunoglobulin and Methylprednisolone Refractory Multisystem Inflammatory Syndrome in Children (MIS-C) in Steroid-Dependent Nephrotic Syndrome Following Rituximab
por: Pal, Priyankar, et al.
Publicado: (2022)

Calcineurin inhibitor induced nephrotoxicity in steroid resistant nephrotic syndrome
por: Sinha, A., et al.
Publicado: (2013)

Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol
por: Ravani, Pietro, et al.
Publicado: (2017)

Circulating Anti-Rituximab Antibodies Do Not Affect Response to Rituximab in Steroid-Dependent Nephrotic Syndrome
por: Angeletti, Andrea, et al.
Publicado: (2022)

Use of rituximab in paediatric nephrology
por: Sinha, Rajiv, et al.
Publicado: (2021)

High Incidence of COL4A Genetic Variants Among a Cohort of Children With Steroid-Resistant Nephrotic Syndrome From Eastern India
por: Sinha, Rajiv, et al.
Publicado: (2022)

Long-Term Outcomes in Children with Steroid-Resistant Nephrotic Syndrome Treated with Calcineurin Inhibitors
por: Beins, Nathan T., et al.
Publicado: (2015)

Steroid Sensitive Nephrotic Syndrome: Revised Guidelines
por: Sinha, Aditi, et al.
Publicado: (2021)

Rituximab therapy in adults with steroid-dependent nephrotic syndrome
por: Zhong, Hongzhen, et al.
Publicado: (2019)

Letter to the editor regarding “The efficacy and safety of infliximab and calcineurin inhibitors in steroid-refractory UC patients: A meta-analysis”
por: Zhu, Qingcheng, et al.
Publicado: (2022)

Calcineurin inhibitors in steroid and anti‐TNF‐alpha refractory immune checkpoint inhibitor colitis
por: Zhang, Eva, et al.
Publicado: (2021)

Difficulties in diagnosing severe Pneumocystis jiroveci pneumonia after rituximab therapy for steroid-dependent nephrotic syndrome
por: Czarniak, Piotr, et al.
Publicado: (2013)

Rituximab, Mycophenolic Acid, and Calcineurin Inhibitors Achieve Long-Term Remission in Pediatric Focal Segmental Glomerulosclerosis with Steroid-Resistant and Frequently Relapsing Nephrotic Syndrome: A Report of Two Cases
por: Ambarsari, Cahyani Gita, et al.
Publicado: (2022)

Long-Term Efficacy and Safety of Rituximab Versus Tacrolimus in Children With Steroid Dependent Nephrotic Syndrome
por: Basu, Biswanath, et al.
Publicado: (2023)

Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
por: Iijima, Kazumoto, et al.
Publicado: (2017)

The efficacy and safety of infliximab and calcineurin inhibitors in steroid-refractory UC patients: A meta-analysis
por: Zhao, Heng-Nan, et al.
Publicado: (2021)

A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome
por: Xu, Jing, et al.
Publicado: (2021)

Comparison of rituximab, cyclophosphamide, and tacrolimus as first steroid-sparing agents for complicated relapsing/steroid-dependent nephrotic syndrome in children: an evaluation of the health-related quality of life
por: Wang, Li, et al.
Publicado: (2022)

Therapy with the Combination of Tolvaptan and Furosemide for Refractory Edema in Nephrotic Syndrome
por: Meena, Jitendra, et al.
Publicado: (2020)

Commensalism or symbiosis: The potential use of rituximab in steroid-refractory Evans syndrome in a patient with ulcerative colitis
por: Ahmed, Eyad, et al.
Publicado: (2021)

Long-term repeated rituximab treatment for childhood steroid-dependent nephrotic syndrome
por: Kim, Ji Hyun, et al.
Publicado: (2017)

Children with Steroid Dependent Nephrotic Syndrome: Rituximab or Tacrolimus? It’s All in the Timing
por: Qader, Md Abdul, et al.
Publicado: (2023)

Early calcineurin-inhibitor to belatacept conversion in steroid-free kidney transplant recipients
por: Tawhari, Ibrahim, et al.
Publicado: (2022)

Steroid-refractory immune thrombocytopenia in the era of the new thrombomimetic drugs: is there still a role for rituximab?
por: Palombi, Massimiliano, et al.
Publicado: (2016)

Rituximab treatment for refractory nephrotic syndrome in adults: a multicenter retrospective study
por: Ma, Xiaoyan, et al.
Publicado: (2023)

Refractory giardiasis in a child with steroid-resistant nephrotic syndrome
por: Kalita, Jitu Mani, et al.
Publicado: (2023)

Hypokalemia After Rituximab Administration in Steroid-Dependent Nephrotic Syndrome: A Case Report
por: Guzzi, Francesco, et al.
Publicado: (2020)

Population Pharmacokinetics of Rituximab in Pediatric Patients With Frequent-Relapsing or Steroid-Dependent Nephrotic Syndrome
por: Chen, Yewei, et al.
Publicado: (2021)

Necrotizing Fasciitis: A Side Effect of Rituximab Administration in Steroid-Dependent Nephrotic Syndrome
por: Safdar, Osama Yousif, et al.
Publicado: (2022)

Calcineurin Inhibitors and COVID-19
por: Hage, René, et al.
Publicado: (2022)

Calcineurin Inhibitors and COVID-19
por: Hage, René, et al.
Publicado: (2022)

Cost-Effectiveness of Administering Rituximab for Steroid-Dependent Nephrotic Syndrome and Frequently Relapsing Nephrotic Syndrome: A Preliminary Study in Japan
por: Takura, Tomoyuki, et al.
Publicado: (2017)

Rituximab for nephrotic syndrome in children
por: Iijima, Kazumoto, et al.
Publicado: (2016)

RE: Steroid-resistant nephrotic syndrome: impact of genetic testing
por: Mubarak, Muhammed, et al.
Publicado: (2014)

The efficacy and safety of rituximab in treating childhood refractory nephrotic syndrome: A meta-analysis
por: Zhao, Zhihong, et al.
Publicado: (2015)

Refractory Myasthenia Gravis Treated Successfully with Rituximab: A Case Report
por: Rahul, L Yadav, et al.
Publicado: (2017)

Systematic Review and Meta-Analysis of Rituximab for Steroid-Dependent or Frequently Relapsing Nephrotic Syndrome in Children
por: Gao, Xia, et al.
Publicado: (2021)

The outcome of rituximab in treating steroid dependent nephrotic syndrome.: Histopathology and immunosuppressive drugs as predicting factors
por: Al Salloum, Abdullah A., et al.
Publicado: (2022)

Efficacy of rituximab versus tacrolimus in difficult-to-treat steroid-sensitive nephrotic syndrome: an open-label pilot randomized controlled trial
por: Mathew, Georgie, et al.
Publicado: (2022)

Reply to RE: Steroid-resistant nephrotic syndrome: impact of genetic testing
por: Kari, Jameela Abdulaziz
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_oncoi1ltc1qrj2276kcuivdnaa